$0.00 EPS Expected for Innovative Industrial Properties (IIPR), Minerva Neurosciences (NERV) SI Decreased By 7.96%

May 25, 2017 - By Richard Conner

Minerva Neurosciences Incorporated (NASDAQ:NERV) had a decrease of 7.96% in short interest. NERV’s SI was 1.94M shares in May as released by FINRA. Its down 7.96% from 2.11 million shares previously. With 114,400 avg volume, 17 days are for Minerva Neurosciences Incorporated (NASDAQ:NERV)’s short sellers to cover NERV’s short positions. The SI to Minerva Neurosciences Incorporated’s float is 8.58%. The stock increased 0.68% or $0.05 on May 24, reaching $7.35. About shares traded. Minerva Neurosciences Inc (NASDAQ:NERV) has risen 56.56% since May 25, 2016 and is uptrending. It has outperformed by 39.86% the S&P500.

Analysts expect Innovative Industrial Properties Inc (NYSE:IIPR) to report $0.00 EPS on June, 28. The stock increased 1.90% or $0.33 on May 24, reaching $17.68. About shares traded. Innovative Industrial Properties Inc (NYSE:IIPR) has 0.00% since May 25, 2016 and is . It has underperformed by 16.70% the S&P500.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $257.44 million. The Firm is focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. It currently has negative earnings. The Company’s product portfolio and indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder (MDD); MIN-117, for the treatment of MDD, and MIN-301 for the treatment of Parkinson’s disease.

Among 2 analysts covering Minerva Neurosciences (NASDAQ:NERV), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Minerva Neurosciences had 3 analyst reports since March 9, 2016 according to SRatingsIntel. The rating was maintained by JMP Securities on Wednesday, March 9 with “Market Outperform”. Jefferies reinitiated Minerva Neurosciences Inc (NASDAQ:NERV) rating on Thursday, May 12. Jefferies has “Buy” rating and $10 target. Jefferies maintained it with “Buy” rating and $17 target in Friday, May 27 report.

Innovative Industrial Properties, Inc. is focused on the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. The company has market cap of $62.34 million. The Firm intends to acquire its properties through sale-leaseback transactions and third-party purchases. It currently has negative earnings. It is focused on leasing its properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including maintenance, taxes and insurance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: